Hyperwell editorial · 2 minute read
Ask which part is off-label
Request the exact product and ask how the proposed use differs from the approved labeling. FDA’s patient guidance explains the general term; the treating clinician should explain the actual proposal. Do not assume that off-label means the same thing as a compounded or unapproved product. These distinctions need separate answers.
Understand the clinical rationale
Ask why the option is being considered for your circumstances and what evidence supports it. Discuss relevant alternatives and the important uncertainties. If an advertisement uses the term without explaining the specific use, bring the original wording to the consultation rather than filling in the missing details yourself.
Clarify informed consent and follow-up
Ask how the proposed use affects the risk discussion, monitoring, expected limitations, and costs. Take time to review the explanation if needed. This article does not recommend an off-label treatment or establish that a particular use is appropriate, lawful, available, or within a clinician’s scope in your location.
Make the conversation yours
Questions to take with you.
- Which part of the proposed use is off-label?
- Why consider it instead of the alternatives?
- What uncertainty and follow-up should I understand?
Independent reading
Background reading, not an endorsement.
